GE Healthcare will be sponsoring a series of calls for proposals for our Invenia ABUS product starting in June 2018 focusing on different topics related to Automated Breast Ultrasound (ABUS). The first call, Retrospective Data Review, as well as second call, Prospective Research, have both announced winners!
Beginning in June 2018, GE Healthcare will be sponsoring a series of at least two calls for proposals (CFP) for our InveniaTM ABUS product (“ABUS CFP Series”), with the focus of each call on a different topic related to Automated Breast Ultrasound (ABUS). The ABUS CFP Series will feature the following calls:
The ABUS CFP 2: Prospective Research seeks to leverage both established Invenia ABUS programs and prospective new users with interest in prospective clinical research. Proposals may address any aspect of the impact of ABUS on breast imaging.
Up to four (4) winners will receive up to (USD) $100,000 each in grant funding (a “grant award”) for up to a three-year period, as well as an Invenia ABUS equipment loan (if requested), to support prospective research addressing any aspect of breast imaging.